142 related articles for article (PubMed ID: 22263930)
1. Delivery of floxuridine derivatives to cancer cells by water-soluble organometallic cages.
Yi JW; Barry NP; Furrer MA; Zava O; Dyson PJ; Therrien B; Kim BH
Bioconjug Chem; 2012 Mar; 23(3):461-71. PubMed ID: 22263930
[TBL] [Abstract][Full Text] [Related]
2. Drug delivery of lipophilic pyrenyl derivatives by encapsulation in a water soluble metalla-cage.
Mattsson J; Zava O; Renfrew AK; Sei Y; Yamaguchi K; Dyson PJ; Therrien B
Dalton Trans; 2010 Sep; 39(35):8248-55. PubMed ID: 20689885
[TBL] [Abstract][Full Text] [Related]
3. Double targeting of tumours with pyrenyl-modified dendrimers encapsulated in an arene-ruthenium metallaprism.
Pitto-Barry A; Barry NP; Zava O; Deschenaux R; Dyson PJ; Therrien B
Chemistry; 2011 Feb; 17(6):1966-71. PubMed ID: 21274948
[TBL] [Abstract][Full Text] [Related]
4. Cellular delivery of pyrenyl-arene ruthenium complexes by a water-soluble arene ruthenium metalla-cage.
Furrer MA; Schmitt F; Wiederkehr M; Juillerat-Jeanneret L; Therrien B
Dalton Trans; 2012 Jun; 41(24):7201-11. PubMed ID: 22506276
[TBL] [Abstract][Full Text] [Related]
5. Encapsulation of pyrene-functionalized poly(benzyl ether) dendrons into a water-soluble organometallic cage.
Pitto-Barry A; Barry NP; Zava O; Deschenaux R; Therrien B
Chem Asian J; 2011 Jun; 6(6):1595-603. PubMed ID: 21626704
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of cytotoxicity by combining pyrenyl-dendrimers and arene ruthenium metallacages.
Pitto-Barry A; Zava O; Dyson PJ; Deschenaux R; Therrien B
Inorg Chem; 2012 Jul; 51(13):7119-24. PubMed ID: 22716166
[TBL] [Abstract][Full Text] [Related]
7. Excellent correlation between drug release and portal size in metalla-cage drug-delivery systems.
Barry NP; Zava O; Dyson PJ; Therrien B
Chemistry; 2011 Aug; 17(35):9669-77. PubMed ID: 21735491
[TBL] [Abstract][Full Text] [Related]
8. Anticancer activity of opened arene ruthenium metalla-assemblies.
Barry NP; Zava O; Furrer J; Dyson PJ; Therrien B
Dalton Trans; 2010 Jun; 39(22):5272-7. PubMed ID: 20442944
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the reactivity between a ruthenium hexacationic prism and biological ligands.
Paul LE; Therrien B; Furrer J
Inorg Chem; 2012 Jan; 51(2):1057-67. PubMed ID: 22221272
[TBL] [Abstract][Full Text] [Related]
10. On/off fluorescence emission induced by encapsulation, exchange and reversible encapsulation of a BODIPY-guest in self-assembled organometallic cages.
Gou XX; Peng JX; Das R; Wang YY; Han YF
Dalton Trans; 2019 Jun; 48(21):7236-7241. PubMed ID: 30706912
[TBL] [Abstract][Full Text] [Related]
11. New cytotoxic and water-soluble bis(2-phenylazopyridine)ruthenium(II) complexes.
Hotze AC; Bacac M; Velders AH; Jansen BA; Kooijman H; Spek AL; Haasnoot JG; Reedijk J
J Med Chem; 2003 Apr; 46(9):1743-50. PubMed ID: 12699392
[TBL] [Abstract][Full Text] [Related]
12. Interaction of a ruthenium hexacationic prism with amino acids and biological ligands: ESI mass spectrometry and NMR characterisation of the reaction products.
Paul LE; Therrien B; Furrer J
J Biol Inorg Chem; 2012 Oct; 17(7):1053-62. PubMed ID: 22767102
[TBL] [Abstract][Full Text] [Related]
13. Anticancer activity of osmium metalla-rectangles.
Barry NP; Edafe F; Dyson PJ; Therrien B
Dalton Trans; 2010 Mar; 39(11):2816-20. PubMed ID: 20200707
[TBL] [Abstract][Full Text] [Related]
14. Ruthenium polypyridine complexes of tris-(2-pyridyl)-1,3,5-triazine-unusual building blocks for the synthesis of photochemical molecular devices.
Schwalbe M; Karnahl M; Görls H; Chartrand D; Laverdiere F; Hanan GS; Tschierlei S; Dietzek B; Schmitt M; Popp J; Vos JG; Rau S
Dalton Trans; 2009 May; (20):4012-22. PubMed ID: 19440601
[TBL] [Abstract][Full Text] [Related]
15. Adduction of the human N-ras codon 61 sequence with (-)-(7S,8R,9R,10S)-7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a] pyrene: structural refinement of the intercalated SRSR(61,2) (-)-(7S,8R,9S,10R)-N6-[10-(7,8,9,10- tetrahydrobenzo[a]pyrenyl)]-2'-deoxyadenosyl adduct from 1H NMR.
Zegar IS; Kim SJ; Johansen TN; Horton PJ; Harris CM; Harris TM; Stone MP
Biochemistry; 1996 May; 35(20):6212-24. PubMed ID: 8639561
[TBL] [Abstract][Full Text] [Related]
16. Thiophenolato-bridged dinuclear arene ruthenium complexes: a new family of highly cytotoxic anticancer agents.
Gras M; Therrien B; Süss-Fink G; Zava O; Dyson PJ
Dalton Trans; 2010 Nov; 39(42):10305-13. PubMed ID: 20890536
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and properties of rhenium carbonyl complexes of alpha,alpha'-bis[(1-pyrenyl)pyrazol-1-yl]alkane ligands.
Reger DL; Gardinier JR; Pellechia PJ; Smith MD; Brown KJ
Inorg Chem; 2003 Nov; 42(23):7635-43. PubMed ID: 14606861
[TBL] [Abstract][Full Text] [Related]
18. Penta(pyrenyl)[60]fullerenes: pyrene-pyrene and [60]fullerene-pyrene interactions in the crystal and in solution.
Matsuo Y; Morita K; Nakamura E
Chem Asian J; 2008 Sep; 3(8-9):1350-7. PubMed ID: 18637652
[TBL] [Abstract][Full Text] [Related]
19. Water-soluble molecular capsules: self-assembly and binding properties.
Corbellini F; Knegtel RM; Grootenhuis PD; Crego-Calama M; Reinhoudt DN
Chemistry; 2004 Dec; 11(1):298-307. PubMed ID: 15551310
[TBL] [Abstract][Full Text] [Related]
20. Designing supramolecular liquid-crystalline hybrids from pyrenyl-containing dendrimers and arene ruthenium metallacycles.
Pitto-Barry A; Barry NP; Russo V; Heinrich B; Donnio B; Therrien B; Deschenaux R
J Am Chem Soc; 2014 Dec; 136(50):17616-25. PubMed ID: 25418684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
